Stock Expert AI
Linde plc
LIN - NASDAQ - $489.98 ▼ -%0.03
-
Earnings Fri 30 Oct

Linde opens the
books on Friday evening.

6 analysts' median target is $564[FMP target], stock is $490, +15.1% upside potential. After Q2 +0.2% EPS beat[FMP earnings], the stock moved +0.4%.

summary below
Quick Take - in 40 seconds
B
BUY Council 2/6 - Moonshot 46

B = MoonshotScore 46[multi-pillar formula] + Council 2/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q1 consensus: revenue $9.1B[FMP est], EPS $4.53[FMP est]. 8 consecutive quarters of beat[FMP earnings].

$4.53 EPS Estimate Last year $4.33 - +8% YoY YoY
8 Beat Streak Expectations beaten consecutively for the last 8 quarters

Q2 EPS +0.2% beat[FMP] but the stock +0.4% D+1[FMP D+1]. Matthew J. White promised $1.4B CapEx + a sequential decline in Q1 during the Q2 earnings call[Matthew J. White capex transcript].

Watchlist

4 metrics stand out this quarter.

$4.45 Expectation / Guide

Eps Guidance Q3 Fy

eps_guidance_q3_fy

Linde projects Q3 EPS in the range of $4.45 to $4.55, representing 6% to 8% growth, and updated its full-year EPS guidance to $17.70 to $17.90, reflecting 8% to 9% growth.

"Third quarter guidance range is $4.45 to $4.55. Or 6 percent to 8 percent growth. This assumes no currency impact from prior year but does assume a 1 percent FX headwind sequentially. Consistent with prior approach, range assumes no economic improvement at the midpoint. The updated full year range is $17.70 to $17.90. Or 8% to 9 percent growth excluding a 1 percent FX tailwind assumption."

- Matthew J. White - Q2 FY26 Earnings Call - July 31, 2026
30-basis-point Risk Indicator

Us Homecare Margin Drag

us_homecare_margin_drag

Operating margins declined year-over-year, primarily due to the US homecare business (Lincare), which faces headwinds from higher cost inflation and policy changes, despite active portfolio pruning.

"Operating margins, excluding cost pass through, declined approximately 30-basis-point year over year. Primarily driven by the Americas segment. The majority is driven by the U.S. homecare business. Even though we have been actively pruning this portfolio, it simply has not been enough to overcome the continued headwinds led by higher cost inflation, and policy changes."

- Sanjiv Lamba - Q2 FY26 Earnings Call - July 31, 2026
$1 billion Investor Focus

Electronics Market Ai Demand

electronics_market_ai_demand

Electronics remains the fastest-growing end market, with 18% year-over-year growth in Q2, fueled by project startups and increased demand for hardware associated with AI.

"As expected, electronics is the fastest growing end market. With a combination of project start ups, and higher demand tied to hardware associated with AI. As I mentioned earlier, we added $1 billion of new electronic wins to the backlog to support the expansion of advanced node fabs in the Western US. ... electronics, you know, as you saw year on year had 18 percent growth in second quarter."

- Sanjiv Lamba - Q2 FY26 Earnings Call - July 31, 2026
$1 billion Investor Focus

Backlog Record Electronics Wins

backlog_record_electronics_wins

Linde achieved record sales and EPS, increasing its backlog by $1 billion to an all-time high of $8.1 billion, driven by new electronics wins in the US.

"During the second quarter, we achieved record sales and EPS levels. with both growing at near double-digit percent. While increasing the backlog by $1 billion to a record $8.1 billion. After securing a new electronics win in the US."

- Sanjiv Lamba - Q2 FY26 Earnings Call - July 31, 2026

Stock Expert AI - Methodology

Do our scoring pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 2 / 6 Bullish

6 investor frameworks. 2 bullish (Ray Dalio, Buffett), 1 bearish (Ken Griffin), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +15.1%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 39
Klarman value - target upside +15.1%
Buffett quality - ROE score 5/5
Munger valuation - target upside +15.1%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
39.4 RSI 39.4 weak momentum, 50d below
MACD
-4.30 price below 50d - resistance dominant
50d MA
$512 stock 4.3% below - short-term resistance
200d MA
$475 stock 3.2% above - long-term support
Volume (10d)
-32% decrease - low participation
Resistance
$564
Analyst median target - upgrade trigger if broken
Current
$490
Pre-earnings position
Support
$404
Invalidation - close below this is a technical breakdown
Pattern
Range
$404-$564 band - earnings breakout/breakdown trigger

Past Performance

Linde beat expectations in the last 8 quarters.

BEAT
Q3 FY25
$4.21 vs $4.18 est - -1.5%
BEAT
Q4 FY25
$4.20 vs $4.18 est - -2.5%
BEAT
Q1 FY26
$4.33 vs $4.27 est - -2.8%
BEAT
Q2 FY26
$4.50 vs $4.49 est - +0.4%

Q2 (July 31, 2026): EPS $4.50 vs $4.49 est[FMP], +0.2% beat. D+1 movement: +0.4%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $4.39 (no guidance)

Q2: EPS $4.50 vs $4.49 beat[FMP], stock +0.4% D+1[FMP]. Matthew J. White Q2 transcript: "As expected, electronics is the fastest growing end market. With a combination of project start ups, and higher demand tied to hardware associated with AI. As I mentioned earlier, we added $1 billion of new electronic wins to the backlog to support the expansion of advanced node fabs in the Western US. ... electronics, you know, as you saw year on year had 18 percent growth in second quarter."[Matthew J. White].

"As expected, electronics is the fastest growing end market. With a combination of project start ups, and higher demand tied to hardware associated with AI. As I mentioned earlier, we added $1 billion of new electronic wins to the backlog to support the expansion of advanced node fabs in the Western US. ... electronics, you know, as you saw year on year had 18 percent growth in second quarter."

- Matthew J. White, CFO - Q2 FY26 Earnings Call - July 31, 2026
Backlog concentration

No RPO/backlog concentration disclosed in Q2 earnings call.

CapEx shock

Q2 CapEx $1.4B[FMP cashflow]. Q2 op margin 27.3%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $4.53 + CapEx discipline
Threshold: EPS > $4.53[FMP est].
Target: Break above median target $564[FMP target]; high target $612[FMP] upper bound.
Scenario B - In-Line
EPS approx $4.53 + CapEx < $1.4B
Threshold: EPS approx $4.53[FMP est], Q1 CapEx < $1.4B[FMP].
Target: Consolidation in the band between current $490[FMP] and median $564[FMP].
Scenario C - Miss
EPS < $4.39 or CapEx >= $1.4B
Threshold: EPS < $4.39[FMP estx0.97].
Target: Current $490 below SMA200 $475[FMP], if rejection continues, $404[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 6 analysts say?

Wall Street Consensus
$564
12-month median target price (+15.1% upside potential)
20
BUY
6
HOLD
1
SELL
Risk Management
$404
Invalidation level - critical support threshold
$512 - 50-day MA (below, -4.3%)
$475 - 200-day MA (above, +3.2%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - LIN Q1 FY27
B

You read it in 5 minutes. When the numbers come out on Friday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Friday evening. The framework is ready on this page: Q1 EPS threshold $4.53[FMP], CapEx threshold "below $1.4B"[Matthew J. White]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Oct 30, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Oct 31, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Dec 14, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Jan 30, 2027EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the LIN earnings preview cover?

This Linde plc (LIN) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in LIN earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.

Where do the numbers on this page come from?

Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.

Is this a buy or sell recommendation?

No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.

More earnings, decoded